Tall Stories Theatre Company to Have Residency With Nimax Theatres | Playbill

Related Articles
London News Tall Stories Theatre Company to Have Residency With Nimax Theatres

Two productions from the U.K. children's theatre company will be presented in a West End venue every year.

Cast of Room on the Broom

Tall Stories Theatre Company, a 2024 Olivier nominee for The Smeds and The Smoos, has announced a new residency with Nimax Theatres that will begin this summer. Audiences of all ages will be able to enjoy two Tall Stories live productions each year in a West End theatre.

Tall Stories’ adaptation of Julia Donaldson and Axel Scheffler’s The Gruffalo, currently celebrating 25 years since its publication, will kick off the new residency in July at the Lyric Theatre, Shaftesbury Avenue. The Olivier-nominated adaptation of Room on the Broom, penned by the same authors, will run during the holidays.

The West End residency will continue in summer 2025 with The Smeds and The Smoos with The Gruffalo’s Child following in the winter. Additional titles will be announced.

The residencies further Tall Stories' mission that all children should have the opportunity to experience the excitement of live theatre, and access to theatre at a young age is essential for developing a lifelong relationship with the arts.

Tall Stories Marketing Director Clare Lewis said in a statement, "This partnership with Nimax Theatres is a fantastic opportunity for Tall Stories to ensure that theatre for young children and their families is embedded in the West End. The West End residency will create numerous opportunities for us to diversify and develop audiences. As a charity, Tall Stories consciously keeps ticket prices affordable—starting from just £10. We’re looking forward to working together with Nimax to generate more opportunities to break down barriers which prevent families from accessing the magic of theatre."

These West End runs will include accessible performances accommodating Deaf, disabled, visually impaired, and neurodivergent audiences. 

For more information click here.

Today’s Most Popular News:

Blocking belongs
on the stage,
not on websites.

Our website is made possible by
displaying online advertisements to our visitors.

Please consider supporting us by
whitelisting playbill.com with your ad blocker.
Thank you!